471 Inhibiting signalling by erbB receptor tyrosine kinases with AZD8931, a potent reversible small molecule inhibitor, reduces intestinal adenoma formation in the ApcMin/+ mouse model
Alferez, D, Logié, A, Seedhar, P, Poulsom, R, Klinowska, T, Wilkinson, R.W
Published in European journal of cancer supplements (2010)
Published in European journal of cancer supplements (2010)
Get full text
Journal Article